US And Canada

Daily Deal Round Up: June 22, 2021
Maersk Growth and Raed Ventures co-led a $42m round for shipping platform developer Trella while GV exited deep learning software provider Determined AI.
Rising Stars Q&A – Aaron Hoffman, Intact Ventures
Q&A with Aaron Hoffman, senior analyst, Intact Ventures
MetaProp settles third fund at $100m
A number of corporates from the real estate sector have contributed to the property technology-focused venture firm's latest fund.
Blend Labs looks to join public markets
Salesforce-backed lending software producer Blend has raised more than $685m in funding and hit a $3.3bn valuation in its last funding round five months ago.
Century Therapeutics runs to $211m IPO
Bayer and Fujifilm scored exits as the cancer treatment developer floated on the Nasdaq Global Select Market at the top of its range.
Cleerly captures $43m in series B round
The cardiovascular data technology developer has launched with $54m in funding, $43m coming from a Cigna Ventures-backed series B round.
USAA marches to Academy Investor Network
USAA has made an anchor commitment to the military graduate investment network’s first fund, which is targeting $50m for its final close.
Daily Deal Round Up: June 21, 2021
Tencent, Credit Saison and JG Summit have all contributed to a $16m round for GrowSari while Greenvolt is set to acquire up to 29% of solar system installer Perfecta Energía.

Other News

Cyteir captures $133m in initial public offering
Novo and Celgene will retain shares in the cancer therapy developer, which floated at the upper end of its range and which now has a $600m market cap.
Ambrx accesses $126m through IPO
The antibody-based drug developer, which counts WuXi AppTec, Fosun, Sinopharm and Humanwell as investors, has floated in a $126m offering.
Nylas inputs $120m in series C
Slack Fund and Citi Ventures have reinvested in the communications software developer through a round that lifted its overall funding to $175m.
Fractyl finds $100m for series F
Yahoo Japan and Alphabet-backed Fractyl aims to make one of its proposed products a cornerstone therapy for type 2 diabetes, and has now raised about $270m in total.
Rakuten backs in $38m series C
The application management platform developer boosted its overall funding to $86m in a round led by Rakuten Capital.
Introhive buzzes with $100m series C
The Salesforce and Plante Moran-backed customer management software producer plans to make strategic acquisitions with the series C proceeds.

Editor's Picks

Verve Therapeutics beats its way to $267m IPO
GV and Novo-backed cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.
Thumbtack drums up $275m
CapitalG helped the domestic services marketplace almost double its valuation to $3.2bn in a round that boosted its total funding to nearly $700m.
Dave banks on $4bn reverse merger
The Chernin Group, Capital One and Kraft Group-backed banking app developer will get a New York Stock Exchange listing through the deal.
Outreach engages investors to raise $200m
The customer interaction software provider’s Salesforce-backed series G round lifted its total funding to $489m and valued it at $4.4bn.
test reg


Not yet subscribed?

See your subscription offers here